In a retrospective study in China which included 96 patients with pancreatic cancer (Lin et al., 2017), HR of pancreatic cancer mortality associated with elevated CEA reached 2.59 (95% CI [1.17–5.70]). The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.